Literature DB >> 14611145

[Evaluation of disease management programs--current deficits, demands and methods].

Ferdinand M Gerlach1, Martin Beyer, Joachim Szecsenyi, Heiner Raspe.   

Abstract

The evaluation of disease management programmes is necessary and has been made obligatory in Germany by the Fifth Book of Social Code. So far there has been extensive ambiguity as regards the precise definition of suitable strategies for the evaluation. Considering the scientific evaluation of the diabetes contract in North-Rhine current deficits of the evaluation of already existing programmes for chronically ill patients are exemplarily described. On the basis of international experience reasonable demands are discussed that ought to be accomplished when evaluating the effectiveness and benefit of the programmes. Taking the British Medical Research Council as an example, a four-step model will be suggested as a loophole in the methodological dilemma of varying suitable study designs, which allows for the adequate evaluation of even complex interventions.

Entities:  

Mesh:

Year:  2003        PMID: 14611145

Source DB:  PubMed          Journal:  Z Arztl Fortbild Qualitatssich        ISSN: 1431-7621


  8 in total

1.  Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.

Authors:  Karel Kostev; Timo Rockel; Louis Jacob
Journal:  J Diabetes Sci Technol       Date:  2016-07-10

2.  Quality of diabetes care in Austrian diabetic patients willing to participate in a DMP - at baseline.

Authors:  Maria Flamm; Henrike Winkler; Sigrid Panisch; Peter Kowatsch; Gert Klima; Bernhard Fürthauer; Raimund Weitgasser; Andreas C Sönnichsen
Journal:  Wien Klin Wochenschr       Date:  2011-06-22       Impact factor: 1.704

3.  [The stable patient collective as a potential pitfall of prospective primary health-care studies. A qualitative inquiry among general practitioners].

Authors:  Dirk Mosshammer; Gernot Lorenz; Iris Natanzon
Journal:  Med Klin (Munich)       Date:  2009-10-25

Review 4.  Disease management programs for type 2 diabetes in Germany: a systematic literature review evaluating effectiveness.

Authors:  Sabine Fuchs; Cornelia Henschke; Miriam Blümel; Reinhard Busse
Journal:  Dtsch Arztebl Int       Date:  2014-06-27       Impact factor: 5.594

5.  The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial.

Authors:  Andreas C Sönnichsen; Henrike Winkler; Maria Flamm; Sigrid Panisch; Peter Kowatsch; Gert Klima; Bernhard Fürthauer; Raimund Weitgasser
Journal:  BMC Fam Pract       Date:  2010-11-05       Impact factor: 2.497

6.  ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct--a study protocol [ISRCTN08471887].

Authors:  Stefanie Joos; Thomas Rosemann; Marc Heiderhoff; Michel Wensing; Sabine Ludt; Jochen Gensichen; Petra Kaufmann-Kolle; Joachim Szecsenyi
Journal:  BMC Public Health       Date:  2005-10-04       Impact factor: 3.295

7.  Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study.

Authors:  Michael Mehring; Ewan Donnachie; Florian Cornelius Bonke; Christoph Werner; Antonius Schneider
Journal:  Diabetol Metab Syndr       Date:  2017-05-18       Impact factor: 3.320

8.  Effectiveness of the Austrian disease-management-programme for type 2 diabetes: study protocol of a cluster-randomized controlled trial.

Authors:  Andreas C Sönnichsen; Andreas Rinnerberger; Maria G Url; Henrike Winkler; Peter Kowatsch; Gert Klima; Bernhard Fürthauer; Raimund Weitgasser
Journal:  Trials       Date:  2008-06-19       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.